194 related articles for article (PubMed ID: 14765384)
1. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.
van den Bent MJ
Semin Oncol; 2003 Dec; 30(6 Suppl 19):39-44. PubMed ID: 14765384
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
[TBL] [Abstract][Full Text] [Related]
3. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
4. Benefits of adjuvant chemotherapy in high-grade gliomas.
DeAngelis LM
Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide as first-line agent in treating high-grade gliomas: phase II study.
Chibbaro S; Benvenuti L; Caprio A; Carnesecchi S; Pulerà F; Faggionato F; Serino D; Galli C; Andreuccetti M; Buxton N; Gagliardi R
J Neurooncol; 2004; 67(1-2):77-81. PubMed ID: 15072451
[TBL] [Abstract][Full Text] [Related]
6. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide.
Rinne ML; Wen PY
Oncology (Williston Park); 2015 Apr; 29(4):265, 275. PubMed ID: 25952491
[No Abstract] [Full Text] [Related]
7. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
Schiff D
Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
[TBL] [Abstract][Full Text] [Related]
9. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
Kyritsis AP; Levin VA
Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
[TBL] [Abstract][Full Text] [Related]
10. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Wen PY
J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
[No Abstract] [Full Text] [Related]
11. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
Parlato C; Barbarisi M; Moraci M; Moraci A
Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of protracted daily temozolomide for low-grade gliomas in adults.
Kesari S; Schiff D; Drappatz J; LaFrankie D; Doherty L; Macklin EA; Muzikansky A; Santagata S; Ligon KL; Norden AD; Ciampa A; Bradshaw J; Levy B; Radakovic G; Ramakrishna N; Black PM; Wen PY
Clin Cancer Res; 2009 Jan; 15(1):330-7. PubMed ID: 19118062
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
Brada M; Viviers L; Abson C; Hines F; Britton J; Ashley S; Sardell S; Traish D; Gonsalves A; Wilkins P; Westbury C
Ann Oncol; 2003 Dec; 14(12):1715-21. PubMed ID: 14630674
[TBL] [Abstract][Full Text] [Related]
14. The use of temozolomide in recurrent malignant gliomas.
Gaya A; Rees J; Greenstein A; Stebbing J
Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
[TBL] [Abstract][Full Text] [Related]
15. Promises and controversies in the management of low-grade glioma.
Stupp R; Baumert BG
Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
[No Abstract] [Full Text] [Related]
16. Temozolomide for pediatric high-grade gliomas.
Packer RJ
Curr Neurol Neurosci Rep; 2012 Apr; 12(2):111-3. PubMed ID: 22249491
[No Abstract] [Full Text] [Related]
17. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
[TBL] [Abstract][Full Text] [Related]
18. A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report.
Wakabayashi T; Kayama T; Nishikawa R; Takahashi H; Hashimoto N; Takahashi J; Aoki T; Sugiyama K; Ogura M; Natsume A; Yoshida J
J Neurooncol; 2011 Sep; 104(2):573-7. PubMed ID: 21327711
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas.
Yaman E; Buyukberber S; Uner A; Coskun U; Yamac D; Ozturk B; Kaya AO; Yildiz R; Benekli M;
Tumori; 2008; 94(5):674-80. PubMed ID: 19112939
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Olson JD; Riedel E; DeAngelis LM
Neurology; 2000 Apr; 54(7):1442-8. PubMed ID: 10751254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
